Identification of early disease progression in an ALS rat model

Neuroscience Letters

Volumn 415, Issue 3, 2007, Pages 264-268

  Thonhoff, Jason R ^a   Jordan, Paivi M ^a   Karam, Joseph R ^a   Bassett, Brandon L ^a   Wu, Ping ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Amyotrophic lateral sclerosis (ALS); Motor function; Superoxide dismutase 1; Transgenic rat

Indexed keywords

ACUTE PHASE RESPONSE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; FEMALE; MALE; MONITORING; MOTOR ACTIVITY; MOTOR DYSFUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; SYMPTOM;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; ANIMALS, GENETICALLY MODIFIED; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EARLY DIAGNOSIS; EXPLORATORY BEHAVIOR; FEMALE; HUMANS; MALE; MOVEMENT DISORDERS; MUTATION; PREDICTIVE VALUE OF TESTS; RATS; SUPEROXIDE DISMUTASE; SURVIVAL RATE; WEIGHT LOSS;

EID: 33947177318     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.01.028     Document Type: Article

References (20)

1. Andreassen O.A., Dedeoglu A., Klivenyi P., Beal M.F., and Bush A.I. N-acetyl-l-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis. Neuroreport 11 (2000) 2491-2493
2. Azari M.F., Lopes E.C., Stubna C., Turner B.J., Zang D.W., Nicola N.A., Kurek J.B., and Cheema S.S. Behavioural and anatomical effects of systemically administered leukemia inhibitory factor in the SOD1(G93A) (G1H) mouse model of familial amyotrophic lateral sclerosis. Brain Res. 982 (2003) 92-97
3. Bruijn L.I., Miller T.M., and Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 27 (2004) 723-749
4. Chiba T., Yamada M., Sasabe J., Terashita K., Aiso S., Matsuoka M., and Nishimoto I. Colivelin prolongs survival of an ALS model mouse. Biochem. Biophys. Res. Commun. 343 (2006) 793-798
5. Gaudette M., Hirano M., and Siddique T. Current status of SOD1 mutations in familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 1 (2000) 83-89
6. Guo H., Lai L.C., Butchbach M.E.R., Stockinger M.P., Shan X., Bishop G.A., and Lin C.L.G. Increased expression of the glial glutamate transporter EAAT2 modulates excitotoxicity and delays the onset but not the outcome of ALS in mice. Hum. Mol. Genet. 12 (2003) 2519-2532
7. Gurney M.E., Pu H.F., Chiu A.Y., Dalcanto M.C., Polchow C.Y., Alexander D.D., Caliendo J., Hentati A., Kwon Y.W., Deng H.X., Chen W.J., Zhai P., Sufit R.L., and Siddique T. Motor-neuron degeneration in mice that express a human Cu, Zn superoxide-dismutase mutation. Science 264 (1994) 1772-1775
8. Howland D.S., Liu J., She Y.J., Goad B., Maragakis N.J., Kim B., Erickson J., Kulik J., DeVito L., Psaltis G., DeGennaro L.J., Cleveland D.W., and Rothstein J.D. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS). Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 1604-1609
9. Kiaei M., Petri S., Kipiani K., Gardian G., Choi D.K., Chen J.Y., Calingasan N.Y., Schafer P., Muller G.W., Stewart C., Hensley K., and Beal M.F. Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. J. Neurosci. 26 (2006) 2467-2473
10. Klivenyi P., Ferrante R.J., Matthews R.T., Bogdanov M.B., Klein A.M., Andreassen O.A., Mueller G., Wermer M., Kaddurah-Daouk R., and Beal M.F. Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat. Med. 5 (1999) 347-350
11. Matsumoto A., Okada Y., Nakamichi M., Nakamura M., Toyama Y., Sobue G., Nagai M., Aoki M., Itoyama Y., and Okano H. Disease progression of human SOD1 (G93A) transgenic ALS model rats. J. Neurosci. Res. 83 (2006) 119-133
12. Miana-Mena F.J., Munos M.J., Yague G., Mendez M., Moreno M., Ciriza J., Zaragoza P., and Osta R. Optimal methods to characterize the G93A mouse model of ALS. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 6 (2005) 55-62
13. Nagai M., Aoki M., Miyoshi I., Kato M., Pasinelli P., Kasai N., Brown R.H., and Itoyama Y. Rats expressing human cytosolic copper-zinc superoxide dismutase transgenes with amyotrophic lateral sclerosis: associated mutations develop motor neuron disease. J. Neurosci. 21 (2001) 9246-9254
14. Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., Oregan J.P., Deng H.X., Rahmani Z., Krizus A., Mckennayasek D., Cayabyab A., Gaston S.M., Berger R., Tanzi R.E., Halperin J.J., Herzfeldt B., Vandenbergh R., Hung W.Y., Bird T., Deng G., Mulder D.W., Smyth C., Laing N.G., Soriano E., Pericakvance M.A., Haines J., Rouleau G.A., Gusella J.S., Horvitz H.R., and Brown R.H. Mutations in Cu/Zn superoxide-dismutase gene are associated with familial amyotrophic-lateral-sclerosis. Nature 362 (1993) 59-62
15. Storkebaum E., Lambrechts D., Dewerchin M., Moreno-Murciano M.P., Appelmans S., Oh H., Van Damme P., Rutten B., Man W.Y., De Mol M., Wyns S., Manka D., Vermeulen K., Van den Bosch L., Mertens N., Schmitz C., Robberecht W., Conway E.M., Collen D., Moons L., and Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci. 8 (2005) 85-92
16. Tarasenko Y.I., Nie L., McAdoo D., Johnson K., Hulsebosch C., Grady J., and Wu P. Survival differentiation of human neural stem cells in contusion-injured rat spinal cord. J. Neurosci. Res. 85 (2007) 47-57
17. Tchekalarova J., Kubova H., and Mares P. Postnatal caffeine exposure: effects on motor skills and locomotor activity during ontogenesis. Behav. Brain Res. 160 (2005) 99-106
18. Van den Bosch L., Tilkin P., Lemmens G., and Robberecht W. Minocycline delays disease onset and mortality in a transgenic model of ALS. Neuroreport 13 (2002) 1067-1070
19. Wang L.J., Lu Y.Y., Muramatsu S., Ikeguchi K., Fujimoto K., Okada T., Mizukami H., Matsushita T., Hanazono Y., Kume A., Nagatsu T., Ozawa K., and Nakano I. Neuroprotective effects of glial cell line-derived neurotrophic factor mediated by an adeno-associated virus vector in a transgenic animal model of amyotrophic lateral sclerosis. J. Neurosci. 22 (2002) 6920-6928
20. Zhu S., Stavrovskaya I.G., Drozda M., Kim B.Y.S., Ona V., Li M.W., Sarang S., Liu A.S., Hartley D.M., Du C.W., Gullans S., Ferrante R.J., Przedborski S., Kristal B.S., and Friedlander R.M. Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice. Nature 417 (2002) 74-78